# Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

> **NCT00410488** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 51 (actual)

## Conditions studied

- Sarcoma
- Nausea
- Vomiting

## Interventions

- **DRUG:** Palonosetron - Single Dose
- **DRUG:** Palonosetron - Triple Dose
- **DRUG:** Adriamycin
- **DRUG:** Ifosfamide chemotherapy (AI)
- **DRUG:** Zinecard
- **DRUG:** Mesna
- **DRUG:** Vincristine
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT00410488
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2013-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410488, "Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00410488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*